Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis
Authors:
- Nasim MavaddatNMNasim Mavaddat
- Daniel R. BarnesDBDaniel R. Barnes
- Kyriaki MichailidouKMKyriaki Michailidou
- Goska LeslieGLGoska Leslie
- Joe DennisJDJoe Dennis
- EmbraceEMEmbrace
- Munaza AhmedMAMunaza Ahmed
- Julian BarwellJBJulian Barwell
Open Access
- 30 March 2026
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 134 (10) , 1479-1487
Abstract
Background: The influence of age at menarche (AAM) and age at natural menopause (ANM) on breast cancer (BC) risk in BRCA1 and BRCA2 germline pathogenic variant (PV) carriers is uncertain. Observational studies are prone to bias and have limited statistical power. Mendelian randomization (MR) minimises bias and may be used to examine causal effects. Methods: Two-sample and age-specific MR analyses for BC were performed. For AAM, two-sample multivariable MR and mediation analyses to account for the confounding effect of body mass index (BMI), were undertaken. Results: Genetic scores for ANM and AAM predicted the respective traits in PV carriers. Inverse-variance weighted hazard ratios (HR) for genetically predicted ANM per-year were HR = 0.99 (95%CI:0.97–1.01, p = 0.45) and HR = 1.04 (95% CI:1.01–1.06, p = 0.003) for BRCA1 and BRCA2 PV carriers, respectively. After adjusting for genetic associations with BMI, AAM per-year on BC risk were HR = 0.90 (95%CI:0.83–0.98, p = 0.01) and HR = 0.95 (95%CI:0.86–1.04, p = 0.26) for BRCA1 and BRCA2 carriers, respectively, consistent with a protective effect of later AAM. Discussion: MR analyses support causal associations between ANM and BC risk in BRCA2 , but not BRCA1 , and between AAM and BC risk in BRCA1 and BRCA2 PV carriers. These results may aid risk prediction models and genetic counselling of carriers.Keywords
This publication has 57 references indexed in Scilit:
- Menarche and Time to Cycle Regularity Among Individuals Born Between 1950 and 2005 in the USJAMA Network Open, 2024
- A Bayesian approach to Mendelian randomization using summary statistics in the univariable and multivariable settings with correlated pleiotropyThe American Journal of Human Genetics, 2024
- Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility GenesJAMA Oncology, 2022
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities studyInternational Journal of Cancer, 2020
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasCell Reports, 2018
- Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studiesInternational Journal of Cancer, 2015
- Vector Generalized Linear and Additive Models2015
- Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk MutationsGenetic Epidemiology, 2012
- A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genesGenetic Epidemiology, 2005